Actively Recruiting

Phase Not Applicable
Age: 1Year +
All Genders
NCT07445984

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

Led by Azienda Ospedaliero-Universitaria di Parma · Updated on 2026-03-03

250

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study will be conducted retrospectively and prospectively, using bone marrow (BM) or peripheral blood (PB) samples or biopsies of lymph nodes or tissues with metastatic involvement taken from previously stored samples here at the University Hospital of Parma or taken from patients that need to underwent diagnostic evaluation for a suspect or a defined diagnosis of hematological malignancies collected at the University Hospital of Parma.

CONDITIONS

Official Title

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

Who Can Participate

Age: 1Year +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient aged >1 year old, referred for evaluation to the University Hospital of Parma
  • Retrospective study: previously diagnosed patients with hematological malignancies
  • Prospective study includes patients with clinical suspicion of hematological malignancies requiring diagnostic assessment using peripheral blood, bone marrow aspirate/biopsy, lymph node biopsies, or biopsies of metastatic tissues including liquor from rachicentesis or tissue aspirate
  • Patients suspected of relapsed or refractory onco-hematological disorders needing diagnostic assessment with bone marrow aspirate/biopsy or biopsies of metastatic tissues
  • Patients progressing to blastic transformation from chronic conditions or suspected relapsed/refractory hematological disease requiring diagnostic assessment
  • Written informed consent; for retrospective study, consent is signed during the first follow-up visit
Not Eligible

You will not qualify if you...

  • Age less than 1 year old
  • Patients unable to provide informed consent prior to any procedure for any reason

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Parma

Parma, PR, Italy, 43126

Actively Recruiting

Loading map...

Research Team

G

Giovanni Roti, Associate Professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here